Parabolic Drugs Ltd

BSE: 533211
₹5.70
▼ -0.29 (-4.84%)
Jan. 25, 2021 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
90/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
125.0
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

1 of 2 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

2 of 4 met
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.8%
Low 5.7000 · High 5.7000
1W return
-4.8%
Low 5.7000 · High 5.7000
1M return
32.3%
Low 4.3000 · High 6.9600
52W return
141.5%
Low 1.0000 · High 6.9600
Lifetime High ₹68.8000 (Nov. 12, 2010)
Lifetime Low ₹0.6200 (Aug. 2, 2019)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish1
5D
6.0
10D
5.7
20D
5.0
50D
3.9
100D
3.2
200D
2.4

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

5.70
Pivot
First resistance5.70
Second resistance5.70
Third resistance5.70
First support5.70
Second support5.70
Third support5.70
Day RSI69.1
Day MFI88.3
Day MACD0.88
Day MACD signal0.82

Beta

1M—
3M-0.39
1Y0.29
3Y0.36

Price change analysis

↑ 32.3%
Over 1 Month
LowHigh
4.306.96
↑ 150.0%
Over 3 Months
LowHigh
2.056.96
↑ 126.2%
Over 6 Months
LowHigh
2.056.96
↑ 141.5%
Over 1 Year
LowHigh
1.006.96
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Dec 2020
  • Promoter37.79%
  • FII/FPI8.06%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 37.79% in Dec 2020 qtr

Historical fii holding

FII/FPI holdings were unchanged at 8.06% in Dec 2020 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
10 Nov 2010 STANDARD CHARTERED BANK (MAURITIUS) LIMITED A/C EMERGING IND Bulk Sell 588,485 60.1100 BSE
1 Jul 2010 INDEA LONG TERM OPPORTUNITIES MASTER FUND Bulk Buy 350,000 68.5100 BSE
1 Jul 2010 OPG SECURITIES P LTD Bulk Buy 457,744 68.6400 BSE
1 Jul 2010 OPG SECURITIES P LTD Bulk Sell 457,744 68.5600 BSE
1 Jul 2010 CROSSEAS CAPITAL SERVICES PRIVATE LIMITED Bulk Sell 1,192,056 68.1600 BSE
1 Jul 2010 CROSSEAS CAPITAL SERVICES PRIVATE LIMITED Bulk Buy 1,192,097 68.4500 BSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
24 Sep 2012 Annual General Meeting/Dividend Re 0.25 Per Share 0.2500 —
19 Sep 2011 Dividend-Re.0.50 Per Share 0.5000 —

Corporate Actions

Full history (9 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
19 Sep 2018OTHER Annual General Meeting
21 Sep 2017OTHER Annual General Meeting
21 Sep 2016OTHER Annual General Meeting
21 Sep 2015OTHER Annual General Meeting
25 Sep 2014OTHERAnnual General Meeting

All corporate actions →

Corporate Announcements

All 214 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
4 Aug 2021 Voluntary Delisting ��Members of the Exchange are hereby informed that the admission to dealings in securities of��Parabolic Drugs Limited��shall be withdrawn (delisted) w.e.f. August 11, 2021 Pursuant to Resolution plan Approved by Hon'ble National Company Law Tribunal (NCLT) Under Section 31 of the Insolvency and Bankruptcy Code (IBC), 2016."
12 Feb 2021 Financial Result Updates Parabolic Drugs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.
11 Feb 2021 Outcome of Board Meeting Parabolic Drugs Limited has informed the Exchange regarding Board meeting held on February 11, 2021 for approval of un-audited financial results for quarter and nine month ended 31.12.2020
8 Feb 2021 Corporate Insolvency Resolution Process Parabolic Drugs Limited has informed the Exchange about Corporate Insolvency Resolution Process regarding public announcement for delisting of share and reduction of share capital.
25 Jan 2021 Suspension of Trading Members of the Exchange are hereby informed that the trading in equity shares of Parabolic Drugs Limited (ISIN: INE618H01016) shall be suspended w.e.f January 28, 2021 on account of Record date submitted for the purpose of Delisting pursuant to Resolution Plan approved by NCLT
25 Jan 2021 Record Date Parabolic Drugs Limited has informed the Exchange that Record date for the purpose of of Suspension of Trading of Units under Delisting procedure is 29-Jan-2021.
22 Jan 2021 Certificate under SEBI (Depositories and Participants) Regulations, 2018 Parabolic Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
22 Jan 2021 Updates Parabolic Drugs Limited has informed the Exchange regarding 'Justification for No Payout to the Shareholders of Parabolic Drugs Limited ( Company/Corporate Debtor )'.
19 Jan 2021 Updates Parabolic Drugs Limited has informed the Exchange regarding 'Intimation regarding Delisting of Shares pursuant to the Resolution plan approved by Hon ble NCLT, Chandigarh Bench '.
16 Jan 2021 Corporate Insolvency Resolution Process Parabolic Drugs Limited has informed the Exchange about Corporate Insolvency Resolution Process

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Parabolic Drugs Ltd

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.